{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:56:05Z","timestamp":1788306965001,"version":"build-2803163510"},"reference-count":24,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"crossref","award":["NIHR200915"],"award-info":[{"award-number":["NIHR200915"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>\n                    Better metrics to compare the impact of different antimicrobials on the gut microbiome would aid efforts to control antimicrobial resistance (AMR). The Antibiotic Resistance in the Microbiome \u2013 Oxford (ARMORD) study recruited inpatients, outpatients, and healthy volunteers in Oxfordshire, UK, who provided stool samples for metagenomic sequencing. Data on previous antimicrobial use and potential confounders were recorded. Exposures to each antimicrobial were considered as factors in a multivariable linear regression, also adjusted for demographics, with separate analyses for those contributing samples cross-sectionally or longitudinally. Outcomes were Shannon diversity and relative abundance of specific bacterial taxa (\n                    <jats:italic>Enterobacteriaceae<\/jats:italic>\n                    ,\n                    <jats:italic>Enterococcus<\/jats:italic>\n                    , and major anaerobic groups) and antimicrobial resistance genes (targeting beta-lactams, tetracyclines, aminoglycosides, macrolides, and glycopeptides). 225 adults were included in the cross-sectional analysis, and a subset of 79 patients undergoing haematopoietic cell transplant provided serial samples for longitudinal analysis. Results were largely consistent between the two sampling frames. Recent use of piperacillin-tazobactam, meropenem, intravenous co-amoxiclav, and clindamycin was associated with large reductions in microbiome diversity and reduced abundance of anaerobes. Exposure to piperacillin-tazobactam and meropenem was associated with a decreased abundance of\n                    <jats:italic>Enterobacteriaceae<\/jats:italic>\n                    and an increased abundance of\n                    <jats:italic>Enterococcus<\/jats:italic>\n                    and major AMR genes, but there was no evidence that these antibiotics had a greater impact on microbiome diversity than iv co-amoxiclav or oral clindamycin. In contrast, co-trimoxazole, doxycycline, antifungals, and antivirals had less impact on microbiome diversity and selection of AMR genes. Simultaneous estimation of the impact of over 20 antimicrobials on the gut microbiome and AMR gene abundance highlighted important differences between individual drugs. Some drugs in the WHO Access group (co-amoxiclav, clindamycin) had similar magnitude impact on microbiome diversity to those in the Watch group (meropenem, piperacillin-tazobactam) with potential implications for acquisition of resistant organisms. Metagenomic sequencing can be used to compare the impact of different antimicrobial agents and treatment strategies on the commensal flora.\n                  <\/jats:p>","DOI":"10.7554\/elife.97751","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T07:25:26Z","timestamp":1721114726000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.97751","source":"Crossref","is-referenced-by-count":7,"title":["The impact of different antimicrobial exposures on the gut microbiome in the ARMORD observational study"],"prefix":"10.7554","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4100-2163","authenticated-orcid":true,"given":"Leon","family":"Peto","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03h2bh287","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford University Hospitals NHS Foundation Trust","place":["Oxford, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Nuffield Department of Medicine, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Nicola","family":"Fawcett","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03h2bh287","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford University Hospitals NHS Foundation Trust","place":["Oxford, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Nuffield Department of Medicine, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Musaiwale M","family":"Kamfose","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03h2bh287","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford University Hospitals NHS Foundation Trust","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Claire","family":"Scarborough","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03h2bh287","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford University Hospitals NHS Foundation Trust","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Andy","family":"Peniket","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03h2bh287","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford University Hospitals NHS Foundation Trust","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Robert","family":"Danby","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03h2bh287","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford University Hospitals NHS Foundation Trust","place":["Oxford, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/01ge67z96","id-type":"ROR","asserted-by":"publisher"}],"name":"Anthony Nolan Research Institute, Royal Free Hospital, Hampstead","place":["London, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Timothy EA","family":"Peto","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03h2bh287","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford University Hospitals NHS Foundation Trust","place":["Oxford, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Nuffield Department of Medicine, University of Oxford","place":["Oxford, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0590-2850","authenticated-orcid":true,"given":"Derrick W","family":"Crook","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03h2bh287","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford University Hospitals NHS Foundation Trust","place":["Oxford, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Nuffield Department of Medicine, University of Oxford","place":["Oxford, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Martin J","family":"Llewelyn","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01qz7fr76","id-type":"ROR","asserted-by":"publisher"}],"name":"Brighton and Sussex Medical School","place":["Falmer, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/03wvsyq85","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospitals Sussex NHS Foundation Trust","place":["Brighton, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0412-8509","authenticated-orcid":true,"given":"Ann Sarah","family":"Walker","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03h2bh287","id-type":"ROR","asserted-by":"publisher"}],"name":"Oxford University Hospitals NHS Foundation Trust","place":["Oxford, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Nuffield Department of Medicine, University of Oxford","place":["Oxford, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"4374","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110649","type":"journal-article","article-title":"Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults","volume":"39","author":"Anthony","year":"2022","journal-title":"Cell Reports"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41576-019-0108-4","type":"journal-article","article-title":"Sequencing-based methods and resources to study antimicrobial resistance","volume":"20","author":"Boolchandani","year":"2019","journal-title":"Nature Reviews. Genetics"},{"key":"bib3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00820-19","type":"journal-article","article-title":"Impact of antibiotic gut exposure on the temporal changes in microbiome diversity","volume":"63","author":"Burdet","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/jac\/dkt129","type":"journal-article","article-title":"Community-associated Clostridium difficile infection and antibiotics: a meta-analysis","volume":"68","author":"Deshpande","year":"2013","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"bib5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060280","type":"journal-article","article-title":"The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing","volume":"6","author":"Dethlefsen","year":"2008","journal-title":"PLOS Biology"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S1473-3099(21)00407-2","type":"journal-article","article-title":"The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden","volume":"22","author":"Edlund","year":"2022","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009836","type":"journal-article","article-title":"Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome","volume":"5","author":"Jakobsson","year":"2010","journal-title":"PLOS ONE"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/19490976.2016.1267890","type":"journal-article","article-title":"Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers","volume":"8","author":"Kabbani","year":"2017","journal-title":"Gut Microbes"},{"key":"bib9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29229-5","type":"journal-article","article-title":"Gut bacterial microbiota and its resistome rapidly recover to basal state levels after short-term amoxicillin-clavulanic acid treatment in healthy adults","volume":"8","author":"MacPherson","year":"2018","journal-title":"Scientific Reports"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1586\/14787210.2014.956092","type":"journal-article","article-title":"Mechanisms of antibiotic resistance in enterococci","volume":"12","author":"Miller","year":"2014","journal-title":"Expert Review of Anti-Infective Therapy"},{"key":"bib11","type":"web-resource","article-title":"World Antimicrobial Awareness Week (WAAW)","author":"NHS England","year":"2022","unstructured":"NHS England. 2022. World Antimicrobial Awareness Week (WAAW). https:\/\/www.england.nhs.uk\/long-read\/world-antimicrobial-awareness-week-waaw-2022 [Accessed December 9, 2025]."},{"key":"bib12","type":"web-resource","article-title":"The Review on Antimicrobial Resistance","author":"O\u2019Neill","year":"2016","unstructured":"O\u2019Neill J. 2016. The Review on Antimicrobial Resistance. https:\/\/amr-review.org\/ [Accessed December 9, 2025]."},{"key":"bib13","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-021-00478-6","type":"journal-article","article-title":"Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial","volume":"14","author":"Pickering","year":"2022","journal-title":"Gut Pathogens"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1093\/cid\/civ137","type":"journal-article","article-title":"Determining the long-term effect of antibiotic administration on the human normal intestinal microbiota using culture and pyrosequencing methods","volume":"60 Suppl 2","author":"Rashid","year":"2015","journal-title":"Clinical Infectious Diseases"},{"key":"bib15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28525-z","type":"journal-article","article-title":"Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial","volume":"13","author":"Reyman","year":"2022","journal-title":"Nature Communications"},{"key":"bib16","type":"web-resource","article-title":"National Early Warning Score (NEWS) 2. Updated Report of a Working Party","author":"Royal College of Physicians","year":"2017","unstructured":"Royal College of Physicians. 2017. National Early Warning Score (NEWS) 2. Updated Report of a Working Party. https:\/\/www.rcplondon.ac.uk\/projects\/outputs\/national-early-warning-score-news-2 [Accessed December 9, 2025]."},{"key":"bib17","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-015-0061-0","type":"journal-article","article-title":"Mechanisms of antimicrobial resistance in Gram-negative bacilli","volume":"5","author":"Rupp\u00e9","year":"2015","journal-title":"Annals of Intensive Care"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/S1473-3099(22)00683-1","type":"journal-article","article-title":"The WHO AWaRe Antibiotic Book: providing guidance on optimal use and informing policy","volume":"22","author":"Sharland","year":"2022","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2311","type":"journal-article","article-title":"Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice","volume":"8","author":"Shono","year":"2016","journal-title":"Science Translational Medicine"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jac\/dkt477","type":"journal-article","article-title":"Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis","volume":"69","author":"Slimings","year":"2014","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1473-3099(01)00066-4","type":"journal-article","article-title":"Effect of antimicrobial agents on the ecological balance of human microflora","volume":"1","author":"Sullivan","year":"2001","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/jac\/dkab474","type":"journal-article","article-title":"An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones","volume":"77","author":"Vehreschild","year":"2022","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"e790","DOI":"10.1016\/S2666-5247(23)00147-7","type":"journal-article","article-title":"Gut microbiome perturbation, antibiotic resistance, and Escherichia coli strain dynamics associated with international travel: a metagenomic analysis","volume":"4","author":"Worby","year":"2023","journal-title":"The Lancet. Microbe"},{"key":"dataset1","type":"dataset","article-title":"The Antibiotic Resistance in the Microbiome - Oxford","volume-title":"European Nucleotide Archive","author":"Peto","year":"2025","unstructured":"Peto L, Fawcett N. 2025. The Antibiotic Resistance in the Microbiome - Oxford. European Nucleotide Archive. https:\/\/www.ebi.ac.uk\/ena\/browser\/view\/PRJEB86785. PRJEB86785."}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/97751\/elife-97751-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/97751\/elife-97751-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/97751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:15:57Z","timestamp":1787562957000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/97751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":24,"alternative-id":["10.7554\/eLife.97751"],"URL":"https:\/\/doi.org\/10.7554\/elife.97751","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.06.24303874","asserted-by":"subject"}],"is-same-as":[{"id-type":"doi","id":"10.7554\/eLife.97751.3","asserted-by":"subject"}],"is-version-of":[{"id-type":"doi","id":"10.7554\/eLife.97751.1","asserted-by":"subject"},{"id-type":"doi","id":"10.7554\/eLife.97751.2","asserted-by":"subject"}],"is-supplemented-by":[{"id-type":"accession","id":"PRJEB86785","asserted-by":"subject"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"RP97751"}}